Reviews of Interest

Cytokines in immunogenic cell death: Applications for cancer immunotherapy.

Showalter A, Limaye A, Oyer JL, Igarashi R, Kittipatarin C, Copik AJ, Khaled AR.

Cytokine. 2017 Jun 22;97:123-132. doi: 10.1016/j.cyto.2017.05.024. [Epub ahead of print]

PMID: 28648866


Interleukin-6 in Allogeneic Stem Cell Transplantation: Its Possible Importance for Immunoregulation and As a Therapeutic Target.

Tvedt THA, Ersvaer E, Tveita AA, Bruserud Ø.

Front Immunol. 2017 Jun 8;8:667. doi: 10.3389/fimmu.2017.00667. eCollection 2017. Review.

PMID: 28642760


The role of interleukin 10 in human papilloma virus infection and progression to cervical carcinoma.

Berti FCB, Pereira APL, Cebinelli GCM, Trugilo KP, Brajão de Oliveira K.

Cytokine Growth Factor Rev. 2017 Apr;34:1-13. doi: 10.1016/j.cytogfr.2017.03.002. Epub 2017 Mar 23.

PMID: 28365229


IL-15 signaling in NK cell cancer immunotherapy.

Rautela J, Huntington ND.

Curr Opin Immunol. 2017 Feb;44:1-6. doi: 10.1016/j.coi.2016.10.004. Epub 2016 Nov 11.

PMID: 27835762


Interluekin-17A (IL17A).

Chen K, Kolls JK.

Gene. 2017 May 30;614:8-14. doi: 10.1016/j.gene.2017.01.016. Epub 2017 Jan 22. Review.

PMID: 28122268


IL-17 and IL-22 in immunity: Driving protection and pathology.

Eyerich K, Dimartino V, Cavani A.

Eur J Immunol. 2017 Apr;47(4):607-614. doi: 10.1002/eji.201646723. Review.

PMID: 28295238


The Role of IL-23 and the IL-23/TH 17 Immune Axis in the Pathogenesis and Treatment of Psoriasis.

Girolomoni G, Strohal R, Puig L, Bachelez H, Barker J, Boehncke WH, Prinz JC.

J Eur Acad Dermatol Venereol. 2017 Jun 27. doi: 10.1111/jdv.14433. [Epub ahead of print]

PMID: 28653490


Emerging role of interleukin-31 and interleukin-31 receptor in pruritus in atopic dermatitis.

Furue M, Yamamura K, Kido-Nakahara M, Nakahara T, Fukui Y.

Allergy. 2017 Jul 3. doi: 10.1111/all.13239. [Epub ahead of print] Review.

PMID: 28670717


IL-33: biological properties, functions, and roles in airway disease.

Drake LY, Kita H.

Immunol Rev. 2017 Jul;278(1):173-184. doi: 10.1111/imr.12552. Review.

PMID: 28658560


RIG-I-Like Receptors and Type I Interferonopathies.

Kato H, Oh SW, Fujita T.

J Interferon Cytokine Res. 2017 May;37(5):207-213. doi: 10.1089/jir.2016.0095.

PMID: 28475461


TGF-β regulation of encephalitogenic and regulatory T cells in multiple sclerosis.

Lee PW, Severin ME, Lovett-Racke AE.

Eur J Immunol. 2017 Mar;47(3):446-453. doi: 10.1002/eji.201646716. Epub 2017 Feb 10.

PMID: 28102541


Efficacy, safety and pharmacokinetics of biosimilars of anti-tumor necrosis factor-α agents in rheumatic diseases; A systematic review and meta-analysis.

Komaki Y, Yamada A, Komaki F, Kudaravalli P, Micic D, Ido A, Sakuraba A.

J Autoimmun. 2017 May;79:4-16. doi: 10.1016/j.jaut.2017.02.003. Epub 2017 Feb 13.

PMID: 28209290


The molecular basis for differential type I interferon signaling.

Schreiber G.

J Biol Chem. 2017 May 5;292(18):7285-7294. doi: 10.1074/jbc.R116.774562. Epub 2017 Mar 13.

PMID: 28289098


The role of JAK-STAT signaling pathway and its regulators in the fate of T helper cells.

Seif F, Khoshmirsafa M, Aazami H, Mohsenzadegan M, Sedighi G, Bahar M.

Cell Commun Signal. 2017 Jun 21;15(1):23. doi: 10.1186/s12964-017-0177-y. Review.

PMID: 28637459